Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 2)

v3.19.3
Summary of Significant Accounting Policies (Details 2) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Disaggregation of Revenue [Line Items]        
Total Net Revenues $ 350 $ 66 $ 653 $ 211
Myos Canine Muscle Formula® [Member]        
Disaggregation of Revenue [Line Items]        
Total Net Revenues [1] 132 8 282 11
Yolked® [Member]        
Disaggregation of Revenue [Line Items]        
Total Net Revenues [2] 108 13 229 28
Qurr® [Member]        
Disaggregation of Revenue [Line Items]        
Total Net Revenues [3] 10 40 37 153
Physician Muscle Health Formula [Member]        
Disaggregation of Revenue [Line Items]        
Total Net Revenues [4] 5 5 19
White label [Member]        
Disaggregation of Revenue [Line Items]        
Total Net Revenues [5] $ 100 $ 100
[1] Launched in June 2018
[2] Launched in March 2018
[3] Launched in June 2017
[4] Fortetropin blend for physicians
[5] White label fortetropin blend